The mark consists of The two capitalized words "Strand" and "Smart" concatenated, the two "S"'s remaining capitalized.
Mark For: STRANDSMART™ trademark registration is intended to cover the categories of
>Color is not claimed as a feature of the mark. The mark consists of The two capitalized words "Strand" and "Smart" concatenated, the two "S"'s remaining capitalized.
Research | OneLook Acronym Finder |
Serial Number | 88355426 |
Mark Literal Elements | STRANDSMART |
Mark Drawing Type | 5 - AN ILLUSTRATION DRAWING WITH WORD(S) /LETTER(S)/ NUMBER(S) INSTYLIZED FORM |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2020-04-28 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Raymond Van Dyke |
Attorney Docket Number | Davies - 13 |
Law Office Assigned | M70 |
Employee Name | LAWRENCE, SUSAN KASTRI |
2019-03-25 | Application Filed |
2019-12-17 | Location: TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED |
2019-12-17 | Status: Live/Pending |
2019-12-17 | Transaction Date |
2020-03-03 | Published |
2020-04-28 | Location: INTENT TO USE SECTION |
2020-04-28 | Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six |
Party: | StrandSmart, Inc. |
Address | c/o Adrianna Davies 100 Van Ness, Suite 1612 San Francisco, CALIFORNIA UNITED STATES 94102 |
Legal Entity Type | Corporation |
Legal Entity State | DISTRICT OF COLUMBIA |
Drawing | IMAGE/JPEG | 2019-03-25 |
TEAS RF New Application | MULTI | 2019-03-25 |
Notation to File | XML | 2019-06-04 |
Offc Action Outgoing | XML | 2019-06-04 |
XSearch Search Summary | APPLICATION/XML | 2019-06-04 |
Response to Office Action | MULTI | 2019-12-04 |
Amendment and Mail Process Complete | MULTI | 2019-12-06 |
Offc Action Outgoing | XML | 2019-12-17 |
E-Mail Incoming | TIFF | 2020-01-17 |
Notation to File | XML | 2020-01-21 |
TEAS Request Reconsideration after FOA | MULTI | 2020-01-21 |
Amendment and Mail Process Complete | MULTI | 2020-01-29 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-01-29 |
Notice of Publication | XML | 2020-02-12 |
Notification Of Notice of Publication | XML | 2020-02-12 |
OG Publication Confirmation | APPLICATION/XML | 2020-03-03 |
Notice of Allowance | XML | 2020-04-28 |
IC 005. US 006 018 044 046 051 052. G & S: Diagnostic testing devices, namely, diagnostic kits comprised of a cartridge with microelectrodes therein, each microelectrode having a carbon nanotube film with cancer-specific antibodies or other targeting materials thereon for testing blood samples for detection of cancers, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer; Diagnostic kits comprised of cartridges with microelectrodes therein, each microelectrode having a carbon nanotube film with cancer-specific antibodies or other targeting materials thereon for use with an analysis device for testing of blood for detecting cancers in blood samples, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer
IC 010. US 026 039 044. G & S: Medical devices, namely, diagnostic kits consisting primarily of apparatus with microelectrodes therein, each microelectrode having a carbon nanotube film for use with cancer-specific antibodies or other targeting materials thereon, for analyzing blood samples for detecting cancers in blood samples, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer; Diagnostic testing devices, namely, diagnostic kits comprised of apparatus with microelectrodes therein, each microelectrode having a carbon nanotube film for use with cancer-specific antibodies or other targeting materials thereon, and an analysis device for testing blood samples for detection of cancers, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
CC0000 | Color is not claimed as a feature of the mark. |
Description | Date | Proceeding Number |
---|---|---|
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-04-28 | |
PUBLISHED FOR OPPOSITION | 2020-03-03 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-03-03 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-02-12 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-01-28 | 66121 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-01-28 | 66121 |
ASSIGNED TO LIE | 2020-01-28 | 66121 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-01-28 | |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2020-01-21 | |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2019-12-17 | |
FINAL REFUSAL WRITTEN | 2019-12-17 | 72414 |
FINAL REFUSAL E-MAILED | 2019-12-17 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-12-05 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-12-04 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-12-04 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-06-04 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-06-04 | 72414 |
NON-FINAL ACTION E-MAILED | 2019-06-04 | 6325 |
ASSIGNED TO EXAMINER | 2019-06-04 | 72414 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-04-15 | |
NEW APPLICATION ENTERED IN TRAM | 2019-03-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.